Cargando…

Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer

SIMPLE SUMMARY: Early prediction of response to cancer therapies is critical for treatment personalisation. In patients with locally advanced rectal cancer (LARC) undergoing neoadjuvant chemoradiation therapy (nCRT), delta radiomics applied to mesorectal features could potentially lead to the develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiloiro, Giuditta, Cusumano, Davide, Romano, Angela, Boldrini, Luca, Nicolì, Giuseppe, Votta, Claudio, Tran, Huong Elena, Barbaro, Brunella, Carano, Davide, Valentini, Vincenzo, Gambacorta, Maria Antonietta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296157/
https://www.ncbi.nlm.nih.gov/pubmed/37370692
http://dx.doi.org/10.3390/cancers15123082
_version_ 1785063591471218688
author Chiloiro, Giuditta
Cusumano, Davide
Romano, Angela
Boldrini, Luca
Nicolì, Giuseppe
Votta, Claudio
Tran, Huong Elena
Barbaro, Brunella
Carano, Davide
Valentini, Vincenzo
Gambacorta, Maria Antonietta
author_facet Chiloiro, Giuditta
Cusumano, Davide
Romano, Angela
Boldrini, Luca
Nicolì, Giuseppe
Votta, Claudio
Tran, Huong Elena
Barbaro, Brunella
Carano, Davide
Valentini, Vincenzo
Gambacorta, Maria Antonietta
author_sort Chiloiro, Giuditta
collection PubMed
description SIMPLE SUMMARY: Early prediction of response to cancer therapies is critical for treatment personalisation. In patients with locally advanced rectal cancer (LARC) undergoing neoadjuvant chemoradiation therapy (nCRT), delta radiomics applied to mesorectal features could potentially lead to the development of predictive models of treatment response. Pre- and post-treatment MRIs of patients treated at a single institution were analysed. Radiomic features of the mesorectum and GTV were extracted and predictive models of pathological complete response (pCR) and two-year disease-free survival (2yDFS) were developed. In 203 patients with LARC, a total of 565 variables were evaluated; the best performing 2yDFS prediction model was based on one GTV and two mesorectal features with an AUC of 0.79 in the training set and 0.70 in the validation set. The mesorectum may contain important radiomics information for predicting response to nCRT treatment in LARC patients. ABSTRACT: Background: The aim of this study is to evaluate the delta radiomics approach based on mesorectal radiomic features to develop a model for predicting pathological complete response (pCR) and 2-year disease-free survival (2yDFS) in locally advanced rectal cancer (LARC) patients undergoing neoadjuvant chemoradiotherapy (nCRT). Methods: Pre- and post-nCRT MRIs of LARC patients treated at a single institution from May 2008 to November 2016 were retrospectively collected. Radiomic features were extracted from the GTV and mesorectum. The Wilcoxon–Mann–Whitney test and area under the receiver operating characteristic curve (AUC) were used to evaluate the performance of the features in predicting pCR and 2yDFS. Results: Out of 203 LARC patients, a total of 565 variables were evaluated. The best performing pCR prediction model was based on two GTV features with an AUC of 0.80 in the training set and 0.69 in the validation set. The best performing 2yDFS prediction model was based on one GTV and two mesorectal features with an AUC of 0.79 in the training set and 0.70 in the validation set. Conclusions: The results of this study suggest a possible role for delta radiomics based on mesorectal features in the prediction of 2yDFS in patients with LARC.
format Online
Article
Text
id pubmed-10296157
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102961572023-06-28 Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer Chiloiro, Giuditta Cusumano, Davide Romano, Angela Boldrini, Luca Nicolì, Giuseppe Votta, Claudio Tran, Huong Elena Barbaro, Brunella Carano, Davide Valentini, Vincenzo Gambacorta, Maria Antonietta Cancers (Basel) Article SIMPLE SUMMARY: Early prediction of response to cancer therapies is critical for treatment personalisation. In patients with locally advanced rectal cancer (LARC) undergoing neoadjuvant chemoradiation therapy (nCRT), delta radiomics applied to mesorectal features could potentially lead to the development of predictive models of treatment response. Pre- and post-treatment MRIs of patients treated at a single institution were analysed. Radiomic features of the mesorectum and GTV were extracted and predictive models of pathological complete response (pCR) and two-year disease-free survival (2yDFS) were developed. In 203 patients with LARC, a total of 565 variables were evaluated; the best performing 2yDFS prediction model was based on one GTV and two mesorectal features with an AUC of 0.79 in the training set and 0.70 in the validation set. The mesorectum may contain important radiomics information for predicting response to nCRT treatment in LARC patients. ABSTRACT: Background: The aim of this study is to evaluate the delta radiomics approach based on mesorectal radiomic features to develop a model for predicting pathological complete response (pCR) and 2-year disease-free survival (2yDFS) in locally advanced rectal cancer (LARC) patients undergoing neoadjuvant chemoradiotherapy (nCRT). Methods: Pre- and post-nCRT MRIs of LARC patients treated at a single institution from May 2008 to November 2016 were retrospectively collected. Radiomic features were extracted from the GTV and mesorectum. The Wilcoxon–Mann–Whitney test and area under the receiver operating characteristic curve (AUC) were used to evaluate the performance of the features in predicting pCR and 2yDFS. Results: Out of 203 LARC patients, a total of 565 variables were evaluated. The best performing pCR prediction model was based on two GTV features with an AUC of 0.80 in the training set and 0.69 in the validation set. The best performing 2yDFS prediction model was based on one GTV and two mesorectal features with an AUC of 0.79 in the training set and 0.70 in the validation set. Conclusions: The results of this study suggest a possible role for delta radiomics based on mesorectal features in the prediction of 2yDFS in patients with LARC. MDPI 2023-06-07 /pmc/articles/PMC10296157/ /pubmed/37370692 http://dx.doi.org/10.3390/cancers15123082 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chiloiro, Giuditta
Cusumano, Davide
Romano, Angela
Boldrini, Luca
Nicolì, Giuseppe
Votta, Claudio
Tran, Huong Elena
Barbaro, Brunella
Carano, Davide
Valentini, Vincenzo
Gambacorta, Maria Antonietta
Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer
title Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer
title_full Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer
title_fullStr Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer
title_full_unstemmed Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer
title_short Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer
title_sort delta radiomic analysis of mesorectum to predict treatment response and prognosis in locally advanced rectal cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296157/
https://www.ncbi.nlm.nih.gov/pubmed/37370692
http://dx.doi.org/10.3390/cancers15123082
work_keys_str_mv AT chiloirogiuditta deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer
AT cusumanodavide deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer
AT romanoangela deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer
AT boldriniluca deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer
AT nicoligiuseppe deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer
AT vottaclaudio deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer
AT tranhuongelena deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer
AT barbarobrunella deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer
AT caranodavide deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer
AT valentinivincenzo deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer
AT gambacortamariaantonietta deltaradiomicanalysisofmesorectumtopredicttreatmentresponseandprognosisinlocallyadvancedrectalcancer